The June 19 preferential policy of the medical website will be extended for another five years!
Recently, the ministry of finance, state administration of taxation jointly issued "about advertising and business advertising purchase expenses of pre-tax deduction notice (caishui [2017] no. 41) (hereinafter referred to as" no. 41 "), including advertising and business advertising purchase expenditure pre-tax deduction for pharmaceutical industry directly.
▍ five years retroactive taxes
According to the new tax rules, pharmaceutical companies and pharmaceutical companies can submit a special report for five years of income tax deduction.
According to article 41:
For cosmetics manufacturing or sales, pharmaceutical manufacturing and beverage manufacturing (excluding alcohol manufacturing enterprise of advertising and business advertising purchase expenditure, no more than 30% of the sales (business) income part, allow deducts; In excess of the amount, the deduction shall be made for the subsequent annual tax deduction.
For advertising and publicity expenses allocation agreement associated enterprises (hereinafter referred to as the agreement), one of no more than the sales (business) income within the pre-tax deduction quota proportion of spending on advertising and business costs can be deducted from the proceeds at the time of this enterprise, also some or all of these can be in accordance with the contribution to the other party to deduct the account agreement. Another party in calculating the company advertising and business advertising purchase expenses deducted before duty of enterprise income tax allowance, can according to the above way to summarize the company's advertising and business costs do not count.
No. 41 will be executed from January 1, 2016 to December 31, 2020.
, ernst & young (EY) analysis, no. 41 release continues the original since January 1, 2011 to December 31, 2015, during the execution of caishui [2012] no. 48, namely "about spending on advertising and business advertising purchase pre-tax deduction of the notice of the policy.
According to the 2008 start of the implementation regulations of the law of the People's Republic of China on enterprise income tax law article 44, the enterprise of qualified advertising and business advertising purchase expenditure, except as otherwise prescribed by the competent financial and tax departments under the state council, no more than 15% of the sales (business) income part, allow deducts; In excess of the amount, the deduction shall be made for the subsequent annual tax deduction.
In the past, the advertising fee of cosmetics, medicine, beverage industry and business entertainment expense account for a large proportion of enterprises cost.
In 2009, the fiscal and taxation department will post, to cosmetics, pharmaceutical manufacturing and beverage manufacturing enterprise spending on advertising, business costs, no more than 30% of the sales (business) income part, allow deducts; In excess of the amount, the deduction shall be made for the subsequent annual tax deduction. The policy period was January 1, 2008, December 31, 2010.
In 2012, the tax authorities reissued the policy and extended the above preferential policies to December 31, 2015. This is the second extended period until December 31, 2020.
Ernst &young analysis pointed out that because of the size 41 article published on May 27, 2017, and on 1 June 2017, Japan's website, many apply to sales (business) income 30% limit to deduct spending on advertising and business costs taxpayers have been in accordance with the general provisions, namely enterprise income tax shall be prescribed in article 44 15% of spending on advertising and business advertising purchase deduction quota has completed 2016 annual enterprise income tax payable or refundable amount.
According to the state administration of taxation announced [2012] no. 15, namely on the number of enterprise income tax amount of taxable income tax treatment issues announcement, the enterprise discovery before actual, in accordance with relevant provisions of the tax year shall be deducted before the enterprise income tax deducted or not deduct spending less, can make a special report and accounts, the grant retroactive to the project's annual calculating deduction, but retroactive confirm period shall not exceed 5 years.
That is, the pharmaceutical companies can submit a special report, which will help reduce the tax burden on the drug companies for five years.
▍ biggest spending?
In fact, advertising and business promotion fees have always been a big expense in pharmaceutical companies.
Drugs, from production to access to sales terminals, involve drugs manufacturers, pharmaceutical companies, governments and medical terminals. Promotion cost is mainly used for market expansion and consolidate the brand influence, brand and public relations, etc. - in some marketing company, the ratio exceeded 70%, even becomes the absolute most company a lot of money.
(image: Orient wealth net)
Oriental wealth network after a set of public data shows that in the list of the first half of 2016 listed companies advertising, in advertising in the listed companies in the top 55 and hengrui pharmaceutical, health, method group, China resources san-jiu, baiyun mountain and other 19 pharmaceutical enterprises on the list.
(image: Orient wealth net)
And another set of data and the form to confirm from September, 2016, hundred million bond power network published list of the first half of 2016 listed companies advertising, on the top 20 companies, pharmaceutical manufacturing enterprises accounted for "half".
Another set of statistics show that 2016, 216 listed pharmaceutical companies advertising promotion expenses totaled 45.794 billion yuan, accounting for almost 30% of all a-share companies the expense.
It is not only China, but also the world.
In the past year, pharmaceutical companies have spent $2.2 billion on the promotion of their television ads, according to public data. Nine branded drugs cost more than $100 million.
Occupy the TOP20 list is a AbbVie (AbbVie) for its "love" merlot huge advertising spending of $344 million, compared with $202 million in advertising spending has increased by 70% in 2015 - which, $173 million for arthritis, $118 million for crohn's disease and colitis advertising, advertising $54 million for psoriasis. |
